Stelara 90 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FKKD9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,584
Award facts
- Contract value 100% obligated
- $16,584.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of STELARA 90 mg/ml syringes. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, was made without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated as contract SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative.
DMS Pharmaceutical Group's PPV-G GEN V contract, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning the company as a critical regional pharmaceutical supplier for Department of Defense medical operations. The broader PPV-G GEN V acquisition strategy represents a $30.3 billion government initiative designed to consolidate pharmaceutical sourcing across military healthcare facilities worldwide. Through this contract vehicle, DLA authorizes firm fixed-price delivery orders for a comprehensive pharmaceutical portfolio including branded and generic prescription medications, biologics, vaccines, and medical consumables to support recurring medical supply needs throughout the DoD healthcare system.
Quick answers
Who was awarded contract SPE2DR26FKKD9?
SPE2DR26FKKD9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FKKD9 worth?
The government has obligated $16,584 on SPE2DR26FKKD9.
Is contract SPE2DR26FKKD9 an order under another contract?
Yes. SPE2DR26FKKD9 is a delivery order under SPE2DR25D9367, an indefinite delivery contract.
Was contract SPE2DR26FKKD9 competed?
The extent of competition for SPE2DR26FKKD9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award